EORTC Partners with Medidata to Elevate Oncology Research Efficiency

Wednesday, 11 September 2024, 00:11

EORTC extends its partnership with Medidata to enhance oncology research. This strategic collaboration aims to improve data management and patient engagement capabilities, fortifying the framework for cancer studies.
LivaRava_Medicine_Default.png
EORTC Partners with Medidata to Elevate Oncology Research Efficiency

EORTC and Medidata Partnership

EORTC, a prominent name in cancer research, has extended its partnership with Medidata, a leader in modern data management solutions. This collaboration is set to transform oncology research by integrating innovative technologies for better data management and patient engagement.

Objectives of the Partnership

  • Enhancement of data management capabilities.
  • Improvement of patient engagement strategies.
  • Streamlined processes for clinical trials.

According to Vassilis Golfinopoulos, the headquarters director at EORTC, this partnership decision was influenced by their extensive experience in utilizing the Medidata Platform for oncology research. By leveraging Medidata’s advanced capabilities, EORTC aims to ensure comprehensive data oversight and patient involvement in cancer studies.

Impact on Oncology Research

This extension not only strengthens the EORTC's research foundation but also assists in navigating the dynamic landscape of oncology trials. Improved efficiency in data handling promises to expedite the research timelines, ultimately benefiting patients.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe